Slowing Human Aging: Epigenetic Reprogramming and Senolytics

Slowing human aging is one of the most exciting fields in medical research, showing significant advancements in recent years. Two promising approaches in this area are epigenetic reprogramming and the use of senolytics, both of which could potentially decelerate the aging process.

Epigenetic reprogramming involves modifying the genetic code of cells to reverse signs of aging. This is achieved by altering the DNA methylation patterns, which influence gene expression. Scientists hope that this method can help restore cells to a more youthful state, thereby slowing down aging.

Senolytics are compounds designed to remove aging, or senescent, cells from the body. These cells no longer divide but release inflammatory factors that can damage surrounding tissues. Researchers believe that using senolytics may reduce the risk of age-related diseases such as cardiovascular diseases and neurodegenerative disorders.

Measuring biological age also plays a crucial role in aging research. A study published in PLOS Medicine suggests that accelerated brain aging is linked to various neurological and psychiatric disorders, such as dementia and schizophrenia. Using brain imaging techniques, researchers can determine the brain's biological age, which may differ from chronological age.

Research indicates that the potential to slow aging not only aims to improve quality of life but also to achieve longer lifespans. Both epigenetic reprogramming and the application of senolytics are promising fields that require further investigation but are already generating significant interest within the scientific community.

Image Source: Wikimedia Commons - CC BY-SA 3.0

Sources:
Brain Scans Reveal Which Disorders May Accelerate Brain Aging
The hidden skeleton “gatekeeper” inside brain cells could help fight Alzheimer's
How a medical database developed at MIT evolved into a global standard of data-sharing